Difficulty: Medium
Average Score: 82%
Practice
The priority management of uncomplicated malaria during the second trimester includes administration of
Correct answer
C
Rationale
In the management of uncomplicated malaria during the second trimester of pregnancy, the priority is to ensure effective treatment while minimizing risks to both the mother and the fetus. The correct answer, option C (Artemether lumefantrine), is the preferred choice due to its safety profile in pregnancy. Artemether lumefantrine is an artemisinin-based combination therapy recommended by the World Health Organization for treating malaria in pregnant women during the second and third trimesters.
Option A (Oral quinine) is not the first-line treatment for uncomplicated malaria in pregnancy, as quinine is associated with a higher risk of adverse effects, such as hypoglycemia and cinchonism. Option B (Parenteral quinine) is also not recommended as the first-line treatment for uncomplicated malaria during the second trimester, as oral medications are preferred when feasible to avoid the risks associated with parenteral administration.
Option D (Sulphadoxine pyrimethamine) is primarily used for intermittent preventive treatment in pregnancy to prevent malaria in endemic areas but is not indicated for the treatment of uncomplicated malaria. Understanding the appropriate pharmacological management of malaria in pregnancy is crucial for midwives and healthcare providers to ensure optimal outcomes for both the mother and the developing fetus.
Option A (Oral quinine) is not the first-line treatment for uncomplicated malaria in pregnancy, as quinine is associated with a higher risk of adverse effects, such as hypoglycemia and cinchonism. Option B (Parenteral quinine) is also not recommended as the first-line treatment for uncomplicated malaria during the second trimester, as oral medications are preferred when feasible to avoid the risks associated with parenteral administration.
Option D (Sulphadoxine pyrimethamine) is primarily used for intermittent preventive treatment in pregnancy to prevent malaria in endemic areas but is not indicated for the treatment of uncomplicated malaria. Understanding the appropriate pharmacological management of malaria in pregnancy is crucial for midwives and healthcare providers to ensure optimal outcomes for both the mother and the developing fetus.